SFJ Pharmaceuticals® is a global specialty pharmaceutical company with an innovative pharmaceutical co-development model that provides an advantageous alternative to traditional pharma partnerships. SFJ Pharmaceuticals®’s unique partnering approach provides experienced clinical and medical professionals, clinical development resources and operational oversight and execution to accelerate late-phase drug development candidates across multiple indications and therapeutic areas. The result is pipeline acceleration for our partners.
SFJ Pharmaceuticals® is staffed with a seasoned team of professionals with extensive experience in the global clinical development and regulatory approval of pharmaceutical products.
SFJ Pharmaceuticals® has offices in the United States, Japan, Singapore, Korea, China, Spain and Germany.